Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
4.578
+0.048 (1.06%)
May 5, 2026, 11:37 AM EDT - Market open
Cumberland Pharmaceuticals Employees
Cumberland Pharmaceuticals had 93 employees as of December 31, 2025. The number of employees increased by 2 or 2.20% compared to the previous year.
Employees
93
Change (1Y)
2
Growth (1Y)
2.20%
Revenue / Employee
$478,725
Profits / Employee
-$30,496
Market Cap
68.47M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 93 | 2 | 2.20% |
| Dec 31, 2024 | 91 | 0 | - |
| Dec 31, 2023 | 91 | 6 | 7.06% |
| Dec 31, 2022 | 85 | 2 | 2.41% |
| Dec 31, 2021 | 83 | -7 | -7.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 157 |
| Journey Medical | 58 |
| Assertio Holdings | 53 |
| BioXcel Therapeutics | 29 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
CPIX News
- 5 days ago - RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease - PRNewsWire
- 6 days ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE - PRNewsWire
- 8 days ago - RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights - PRNewsWire
- 12 days ago - Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex - PRNewsWire
- 13 days ago - RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 - PRNewsWire
- 19 days ago - CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE - PRNewsWire
- 7 weeks ago - Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting - PRNewsWire
- 2 months ago - CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PRNewsWire